EUVIMEDEUVIMED entdecken
Klinische StudieOpen Access

Feasibility and preliminary efficacy of the Balance Program to reduce pain‐related disability in pediatric sickle cell disease

Megan E Connolly iD, Sydney Forman, Christina M Sharkey iD, Stephanie Merwin, Deepika S Darbari iD, Steven J Hardy iD

Pediatric Blood & Cancer · 2023

DOI: 10.1002/pbc.30667 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift Pediatric Blood & Cancer, 2023. Verfasst von Megan E Connolly und 5 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Pediatrics and Psychiatry and Behavioral Sciences, George Washington University School of Medicine and Health Sciences, Washington, Di…. Hauptthemen laut MEDLINE: Anemia, Sickle Cell, Pain Management, Pain. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS, NIH National Center for Advancing Translational Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Sickle cell disease (SCD) pain is associated with functional impairment, and treatment is often limited to pharmacological approaches with unwanted side effects. Although behavioral interventions exist for non‐SCD pain populations, interventions designed to address pain‐related impairment in SCD are lacking.

Methods

Twenty youth (9‐17 years) with SCD completed a four‐week telemedicine pain intervention (NCT04388241). Participants and caregivers completed baseline and post‐intervention PROMIS pain measures and the Treatment Evaluation Inventory‐Short Form (TEI‐SF). Descriptive analyses assessed feasibility and acceptability. Reliable Change Index analyses assessed for significant post‐intervention changes in pain functioning. Paired t test analyses compared baseline and post‐intervention opioid prescription fills.

Results

All participants completed at least one treatment session. Eighteen (90%) youth completed all sessions. Youth (100%) and caregivers (94%) rated the intervention as moderately or highly acceptable on the TEI‐SF. Forty‐seven percent of caregivers and 44% of youth reported reliably significant improvements in pain interference after the intervention (median T‐score differences: 24.8 and 23.5, respectively). Sixty‐five percent of caregivers (T‐score improvement difference: 19.3) and 31% of youth (T‐score improvement difference: 32) reported improvements in pain behaviors. There was no significant difference in opioid prescription fills pre‐ and post‐intervention ( P > 0.05).

Conclusions

The Balance Program is feasible, highly acceptable, and can be delivered remotely to reduce barriers to care. Approximately half of youth and caregivers reported significant declines in pain interference following the intervention, with substantial improvements in functioning for treatment responders. Behavioral pain interventions are important adjunctive treatments to uniquely address functional impairment associated with acute and chronic pain in SCD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anemia, Sickle CellPain ManagementPainHumansChildAdolescentMaleFemaleFeasibility StudiesTelemedicineCaregiversPain MeasurementFollow-Up StudiesAnalgesics, Opioid

Stichwörter der Autor:innen

Acceptance and commitment therapycognitive-behavioral therapypainpediatricsickle cell disease

Substanzen

Analgesics, Opioid

Autor:innen und Institutionen

  • Departments of Pediatrics and Psychiatry and Behavioral Sciences, George Washington University School of Medicine and Health Sciences, Washington, District of Columbia, USA.
  • Divisions of Hematology and Oncology, Children's National Hospital, Washington, District of Columbia, USA.
  • Department of Pediatrics, George Washington University School of Medicine and Health Sciences, Washington, District of Columbia, USA.

ORCID-Profile: Megan E Connolly, Christina M Sharkey, Deepika S Darbari, Steven J Hardy

Förderung

  • NCATS NIH HHS
  • NIH National Center for Advancing Translational Sciences

Zitieren

APA

Connolly, M. E., Forman, S., Sharkey, C. M., Merwin, S., Darbari, D. S., & Hardy, S. J. (2023). Feasibility and preliminary efficacy of the Balance Program to reduce pain‐related disability in pediatric sickle cell disease. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.30667

Vancouver

Connolly ME, Forman S, Sharkey CM, Merwin S, Darbari DS, Hardy SJ. Feasibility and preliminary efficacy of the Balance Program to reduce pain‐related disability in pediatric sickle cell disease. Pediatric Blood & Cancer. 2023. doi:10.1002/pbc.30667

BibTeX
@article{Connolly2023,
  author = {Connolly, Megan E and Forman, Sydney and Sharkey, Christina M and Merwin, Stephanie and Darbari, Deepika S and Hardy, Steven J},
  title = {Feasibility and preliminary efficacy of the Balance Program to reduce pain‐related disability in pediatric sickle cell disease},
  journal = {Pediatric Blood & Cancer},
  year = {2023},
  doi = {10.1002/pbc.30667}
}
Kostenlos starten →